Is Aktis Oncology, Inc. (AKTS) a Buy, Sell, or Hold?
NASDAQ : AKTS
Aktis Oncology, Inc. — Institutional Ownership
$23 USD
$0.61 (2.72%)
- Volume
- 321.85K
- Average Volume
- 345K
- Market Capitalization
- $1.23B
- P/E Ratio
- -37.70
- Dividend Yield
- 0.00%
- Price Target
- $35.00
- Year High
- $34.19
- Year Low
- $14.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.49
Institutional Ownership Summary
Institutional Ownership %
0.13%
Investors Holding
14
change: -55 | last: 69
Increased Positions
11
change: -58 | last: 69
Reduced Positions
1
change: 1 | last: 0
New Positions
10
change: -59 | last: 69
Sold Positions
65
change: 65 | last: 0
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: 0 | last: 0
Total Invested
2.26M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2024-02-13 | The Vanguard Group - 23-1945930 | 3.63M | 5.00% |
| 2024-01-26 | (1) BlackRock, Inc. | 5.01M | 6.90% |
| 2023-09-14 | Richard Mashaal | 3.8M | 5.30% |
| 2023-09-14 | Senvest Management, LLC | 3.8M | 5.30% |
| 2022-02-04 | (1)Names of reporting persons. BlackRock, Inc. | 2.97M | 5.70% |
| 2021-02-02 | (1) BlackRock, Inc. | 2.22M | 5.70% |
| 2020-10-02 | Jeffrey B. Shealy | 1.45M | 3.80% |
| 2020-02-13 | Matthew D. Ockner | 512.91K | 1.40% |
| 2020-02-13 | Columbus Capital Management, LLC | 313.41K | 0.90% |
| 2019-02-14 | Matthew D. Ockner | 2.84M | 9.50% |
| 2019-02-14 | Columbus Capital Management, LLC | 2.74M | 9.20% |
| 2018-04-26 | MATTHEW D. OCKNER | 1.75M | 7.80% |
| 2018-04-26 | COLUMBUS CAPITAL MANAGEMENT, LLC | 1.75M | 7.80% |
| 2018-02-15 | Mark N. Tompkins | 1.77M | 7.90% |
| 2018-02-14 | Mark N. Tompkins | 1.77M | 7.90% |
| 2018-02-13 | Jeffrey B. Shealy | 3.28M | 14.70% |
AKTS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $22.40 | 52.52M | $1.18B | $37.78M | $11.55M | $1.15B |
| 2024-12-31 | $22.40 | 34.86M | $780.97M | $37.16M | $12.01M | $755.82M |
| 2023-12-31 | $22.40 | 34.86M | $780.97M | $29.51M | $13.4M | $764.86M |
| 2022-12-31 | $22.40 | 34.86M | $780.97M | $128.6M | $1.78M | $654.15M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17.89 | 55.28M | $988.89M | $371.63M | $11.58M | $628.83M |
| 2025-12-31 | $22.40 | 53.4M | $1.2B | $37.78M | $11.55M | $1.17B |
| 2025-09-30 | $22.40 | 52.52M | $1.18B | $180.25M | $11.86M | $1.01B |
| 2024-12-31 | $22.40 | 52.52M | $1.18B | $37.16M | $12.01M | $1.15B |
| 2024-09-30 | $22.40 | 34.86M | $780.97M | $224.64M | $12.41M | $568.74M |